Literature DB >> 15077649

Transplantation strategies to promote repair of the injured spinal cord.

Mary Bartlett Bunge1, Damien D Pearse.   

Abstract

This review describes the results of the transplantation of Schwann cells and olfactory ensheathing glia in combination with other interventions. The complete transection injury model was used to test the combination of Schwann cell bridges with methylprednisolone, neurotrophins, or olfactory ensheathing glia. The contusion injury model was used to compare Schwann cell and olfactory ensheathing glia transplantation and to examine the results of combining Schwann cell transplants with elevated levels of cyclic adenosine monophosphate. The combination strategies were more effective than cell transplantation alone. The improved regeneration response usually involved a reduction in secondary tissue loss, axonal regeneration from brainstem neurons, an increase in myelinated fibers in the transplant, the exit of regenerated fibers from the transplant into the contiguous cord, and an improvement in locomotor function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15077649     DOI: 10.1682/jrrd.2003.08.0055

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  30 in total

1.  Astrocyte-produced ephrins inhibit schwann cell migration via VAV2 signaling.

Authors:  Fardad T Afshari; Jessica C Kwok; James W Fawcett
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

Review 2.  Matrices and scaffolds for DNA delivery in tissue engineering.

Authors:  Laura De Laporte; Lonnie D Shea
Journal:  Adv Drug Deliv Rev       Date:  2007-04-14       Impact factor: 15.470

3.  Aspiration of a cervical spinal contusion injury in preparation for delayed peripheral nerve grafting does not impair forelimb behavior or axon regeneration.

Authors:  Harra R Sandrow; Jed S Shumsky; Arthi Amin; John D Houle
Journal:  Exp Neurol       Date:  2007-12-15       Impact factor: 5.330

Review 4.  Multipotent skin-derived precursors: adult neural crest-related precursors with therapeutic potential.

Authors:  Karl J L Fernandes; Jean G Toma; Freda D Miller
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-12       Impact factor: 6.237

5.  Multiple channel bridges for spinal cord injury: cellular characterization of host response.

Authors:  Yang Yang; Laura De Laporte; Marina L Zelivyanskaya; Kevin J Whittlesey; Aileen J Anderson; Brian J Cummings; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

Review 6.  Regenerative therapies for central nervous system diseases: a biomaterials approach.

Authors:  Roger Y Tam; Tobias Fuehrmann; Nikolaos Mitrousis; Molly S Shoichet
Journal:  Neuropsychopharmacology       Date:  2013-09-04       Impact factor: 7.853

7.  Modulating Sema3A signal with a L1 mimetic peptide is not sufficient to promote motor recovery and axon regeneration after spinal cord injury.

Authors:  Erik Mire; Nicole Thomasset; Lyn B Jakeman; Geneviève Rougon
Journal:  Mol Cell Neurosci       Date:  2007-10-03       Impact factor: 4.314

Review 8.  Translational spinal cord injury research: preclinical guidelines and challenges.

Authors:  Paul J Reier; Michael A Lane; Edward D Hall; Y D Teng; Dena R Howland
Journal:  Handb Clin Neurol       Date:  2012

9.  Schwann cell LRP1 regulates remak bundle ultrastructure and axonal interactions to prevent neuropathic pain.

Authors:  Sumihisa Orita; Kenneth Henry; Elisabetta Mantuano; Kazuyo Yamauchi; Alice De Corato; Tetsuhiro Ishikawa; M Laura Feltri; Lawrence Wrabetz; Alban Gaultier; Melanie Pollack; Mark Ellisman; Kazuhisa Takahashi; Steven L Gonias; W Marie Campana
Journal:  J Neurosci       Date:  2013-03-27       Impact factor: 6.167

10.  Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods.

Authors:  Courtney Paul; Amer F Samdani; Randal R Betz; Itzhak Fischer; Birgit Neuhuber
Journal:  Spine (Phila Pa 1976)       Date:  2009-02-15       Impact factor: 3.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.